GBBWRPM
BIVV

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-21
Closed -$3K – 467
2017
Q4 		$3K Sell
21
-2
-9% -$109 0.01% 231
2017
Q3 		$1K Hold
23
– – ﹤0.01% 395
2017
Q2 		$1K Hold
23
– – ﹤0.01% 380
2017
Q1 		$2K Buy
+23
New +$1.13K ﹤0.01% 398

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's BIVV Position: Q1 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 21 shares — an estimated $3K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $3K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 21 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $3K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Bioverativ Inc. Common Stock position peaked at $3K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q1 2018, filed 25 Apr 2018.